XML 44 R33.htm IDEA: XBRL DOCUMENT v3.26.3
Subsequent Events - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 14, 2026
Oct. 13, 2026
Oct. 01, 2026
Jul. 22, 2026
Sep. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Jul. 30, 2027
Mar. 31, 2027
Dec. 31, 2025
Subsequent Event [Line Items]                    
Common stock, shares issued         3,324,697 3,324,697       2,349,480
Common stock, par value         $ 0.001 $ 0.001       $ 0.001
Aggregate fair value       $ 5,000 $ 916 $ 916 $ 998      
Common Stock [Member]                    
Subsequent Event [Line Items]                    
Aggregate fair value         $ 1 $ 1        
Common stock issuance         380,469 380,469 338,725      
2020 Equity Incentive Plan [Member] | Common Stock [Member] | Forecast [Member]                    
Subsequent Event [Line Items]                    
Number of stock options vested               50,000    
Subsequent Event [Member]                    
Subsequent Event [Line Items]                    
Percentage of fully diluted outstanding common stock represented by warrant   1.00%                
Period from closing date to first warrant grant   120 days                
Subsequent Event [Member] | Series A-1 and Series A-2 Convertible Preferred Stock [Member]                    
Subsequent Event [Line Items]                    
Payment for repurchase of Preferred Stock, including shares of common stock issued upon conversion   $ 1,600                
Subsequent Event [Member] | Velaris Therapeutics Inc [Member]                    
Subsequent Event [Line Items]                    
Acquisition date   Oct. 13, 2026                
Subsequent Event [Member] | Velaris Therapeutics Inc [Member] | Series B Preferred Stock [Member]                    
Subsequent Event [Line Items]                    
Preferred stock, shares issued   105,286                
Preferred stock, par value   $ 0.001                
Subsequent Event [Member] | Velaris Therapeutics Inc [Member] | Series C Preferred Stock [Member]                    
Subsequent Event [Line Items]                    
Preferred stock, shares issued   33,054                
Preferred stock, par value   $ 0.001                
Number of preferred stock converted into common stock   1,000                
Subsequent Event [Member] | Velaris Therapeutics Inc [Member] | Series C Preferred Stock [Member] | Private Placement [Member]                    
Subsequent Event [Line Items]                    
Common stock issuance 243,063 243,063                
Price per share   $ 1,435.7                
Gross proceeds from issuance of preferred stock in connection with private placement $ 350,000 $ 350,000                
Subsequent Event [Member] | Velaris Therapeutics Inc [Member] | Series B And Series C Non Voting Convertible Preferred Stock [Member]                    
Subsequent Event [Line Items]                    
Number of preferred stock converted into common stock   1,000                
Subsequent Event [Member] | Common Stock [Member] | Velaris Therapeutics Inc [Member] | Private Placement [Member]                    
Subsequent Event [Line Items]                    
Common stock issuance 687,789 687,789                
Price per share   $ 1.4357                
Subsequent Event [Member] | Board of Directors [Member] | Board Service Fees, Services Rendered and Salary Compensation [Member]                    
Subsequent Event [Line Items]                    
Common stock, shares issued     116,103              
Common stock, par value     $ 0.001              
Aggregate fair value     $ 86              
Subsequent Event [Member] | 2020 Equity Incentive Plan [Member] | Common Stock [Member]                    
Subsequent Event [Line Items]                    
Number of stock options granted   60,000                
Exercise price   $ 1.4357                
Subsequent Event [Member] | 2020 Equity Incentive Plan [Member] | Common Stock [Member] | Forecast [Member]                    
Subsequent Event [Line Items]                    
Number of stock options vested                 10,000